Omics Tests and Clinical Trials
NCI and academic collaborators have developed 30 criteria to evaluate the readiness of complex molecular tests to guide decision-making during clinical trials. Using mathematical models, these “omics” tests study genes, proteins, and other types of molecules taken from a biological sample. Omics tests potentially can predict which therapies are most likely to be beneficial.
|•||Checklist for clinical readiness of omics lab tests|
|•||NCI’s Cancer Diagnosis Program|